Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study.
Hanne BlakstadEduardo Erasmo Mendoza MirelesLiv Cathrine HeggebøHenriette MagelssenMette SprautenTom Børge JohannesenEinar Osland Vik-MoHenning LeskePitt NiehusmannKaroline SkogenEirik HelsethKyrre Eeg EmblemPetter BrandalPublished in: Neuro-oncology practice (2023)
promoter with PsP, we also found that absence of neurological deterioration significantly correlated with PsP. Continuation of temozolomide courses did not seem to compromise survival for patients with PD at 3 months post-radiation; therefore, we recommend continuing adjuvant temozolomide courses in case of inconclusive MRI findings.
Keyphrases
- newly diagnosed
- radiation therapy
- end stage renal disease
- chronic kidney disease
- ejection fraction
- magnetic resonance imaging
- early stage
- risk factors
- prognostic factors
- gene expression
- transcription factor
- patient reported outcomes
- brain injury
- magnetic resonance
- rectal cancer
- patient reported
- subarachnoid hemorrhage
- diffusion weighted imaging
- cerebral ischemia
- medical education